These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26321010)

  • 1. Clinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.gov.
    Prasad V; Goldstein JA
    Eur J Cancer; 2015 Nov; 51(17):2718-23. PubMed ID: 26321010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stat bite: Treatment trials in the PDQ clinical trials database, by phase.
    J Natl Cancer Inst; 2004 Sep; 96(18):1355. PubMed ID: 15367566
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of control groups in cardiovascular clinical trials: An analysis of ClinicalTrials.gov from 2009 through 2019.
    Zheutlin AR; Caldwell DJ; Al Danaf J; Shah RU
    Am Heart J; 2021 Apr; 234():133-135. PubMed ID: 33347871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
    Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
    Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in clinical registration trials: is there a real problem?
    Labots G; Jones A; de Visser SJ; Rissmann R; Burggraaf J
    Br J Clin Pharmacol; 2018 Apr; 84(4):700-707. PubMed ID: 29293280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.
    Ataman OU; Sambrook SJ; Wilks C; Lloyd A; Taylor AE; Wedge SR
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e447-54. PubMed ID: 22819210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database.
    Peng H; Chen L; Chen YP; Li WF; Tang LL; Lin AH; Sun Y; Ma J
    PLoS One; 2018; 13(5):e0196730. PubMed ID: 29718970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic inclusion of regions in multiregional clinical trials.
    Song SY; Chee D; Kim E
    Clin Trials; 2019 Feb; 16(1):98-105. PubMed ID: 30444138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of the trial outcome was associated with publication rate and time to publication.
    Song SY; Koo DH; Jung SY; Kang W; Kim EY
    J Clin Epidemiol; 2017 Apr; 84():78-84. PubMed ID: 28238789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.
    Ottaiano A; Mollo E; Di Lorenzo G; Pisano C; Di Maio M; Barletta E; Pensabene M; Segati R; Bullian P; Nasti G; Bryce J; Scala S; Castello G; Ascierto PA
    Cancer Immunol Immunother; 2005 Jan; 54(1):44-50. PubMed ID: 15693138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Representation of older patients in cancer treatment trials.
    Trimble EL; Carter CL; Cain D; Freidlin B; Ungerleider RS; Friedman MA
    Cancer; 1994 Oct; 74(7 Suppl):2208-14. PubMed ID: 8087794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register.
    Fleminger J; Goldacre B
    PLoS One; 2018; 13(3):e0193088. PubMed ID: 29513684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to clinical trial recruitment in head and neck cancer.
    Haddad RI; Chan AT; Vermorken JB
    Oral Oncol; 2015 Mar; 51(3):203-11. PubMed ID: 25593017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of therapeutic cancer vaccine development to population disease burden and five-year survival.
    Dayoub EJ; Davis MM
    Hum Vaccin; 2011 Nov; 7(11):1124-9. PubMed ID: 22048113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Cancer Data Base report on patterns of childhood cancers in the United States.
    Grovas A; Fremgen A; Rauck A; Ruymann FB; Hutchinson CL; Winchester DP; Menck HR
    Cancer; 1997 Dec; 80(12):2321-32. PubMed ID: 9404710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.
    Schwartz LM; Woloshin S; Zheng E; Tse T; Zarin DA
    Ann Intern Med; 2016 Sep; 165(6):421-30. PubMed ID: 27294570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing landscape of phase II/III metastatic sarcoma clinical trials-analysis of ClinicalTrials.gov.
    Que Y; Xiao W; Xu BS; Wen XZ; Weng DS; Zhang X
    BMC Cancer; 2018 Dec; 18(1):1251. PubMed ID: 30545340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOP 09: Statistical design and analysis.
    Onkologie; 2003 Oct; 26 Suppl 6():43-7. PubMed ID: 23570186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.